The statistic, in four numbers
The figure
56 of 57
inspected 503B facilities issued a Form 483
Records
57
rows in the table and the files
Source updated
Nov 2026
FDA table updated
Read by us
Nov 2026
from U.S. Food and Drug Administration
The numbers, to scale
57 inspected facilities, grouped by FDA's "Action Based on Last Inspection" column. Source: FDA register updated November 17, 2026.
Every inspected facility (57), most recent inspection first
| Facility | Location | Last inspection | Form 483 | FDA action listed | Recall |
|---|---|---|---|---|---|
| BSO LLC | Golden, CO | Yes | Open | Not published | |
| Molecular PharmaGroup | New Providence, NJ | Yes | Open | No | |
| Quva Pharma, Inc. | Bloomsbury, NJ | Yes | Open | No | |
| ProRx LLC | Exton, PA | Yes | Open | No | |
| Mark Cuban Cost Plus Manufacturing and Compounding, LLC | Dallas, TX | Yes | Open | No | |
| Eagle Pharma | Birmingham, AL | Yes | Open | No | |
| Leesar Inc. | Fort Myers, FL | Yes | Open | No | |
| Assure Infusions, Inc. | Bartow, FL | Yes | Open | No | |
| Right Value Drug Stores, LLC, dba Carie Boyd's Prescription Shop | Irving, TX | Yes | Open | No | |
| STAQ Pharma, Inc. | Denver, CO | Yes | Open | No | |
| Olympia Pharmaceuticals | Orlando, FL | Yes | Open | No | |
| RC Outsourcing, LLC | Lowellville, OH | Yes | Open | No | |
| Apothecary Pharma, LLC | Cary, NC | Yes | Open | No | |
| Tailstorm Health Inc. | Chandler, AZ | Yes | Open | No | |
| Hybrid Pharma, LLC | Deerfield Beach, CA | Yes | Open | No | |
| STAQ Pharma of Ohio, LLC | Columbus, OH | Yes | Open | No | |
| Imprimis NJOF, LLC | Ledgewood, NJ | Yes | Open | No | |
| IntegraDose Compounding Services, LLC | Shoreview, MN | Yes | Open | No | |
| OurPharma LLC | Fayetteville, AR | Yes | Open | No | |
| Apollo Care | Columbia, MO | Yes | Open | No | |
| Brookfield Medical/Surgical Supply, Inc. | Brookfield, CT | Yes | Open | No | |
| Annovex Pharma, Inc. | Lorton, VA | Yes | Open | No | |
| PQ Pharmacy LLC | Brooksville, FL | Yes | Open | No | |
| SKNV formerly registered as Sincerus Florida, LLC | Pompano Beach, FL | Yes | Open | No | |
| Turbare Manufacturing | Conway, AR | Yes | Response Letter Issued 10/5/2026 | Not published | |
| Quva Pharma, Inc. | Sugar Land, TX | Yes | Response Letter Issued 10/16/2026; FMD-145 Issued 10/19/2026 | No | |
| BPI Labs LLC | Largo, FL | Yes | Open | No | |
| Wells Pharma of Houston, LLC | Houston, TX | Yes | Response Letter Issued 11/12/2026 | No | |
| Wells Pharmacy, Inc. | Dyersburg, TN | Yes | Response Letter Issued 10/5/2026; FMD-145 Letter Issued 10/6/2026 | No | |
| Wesley Pharmaceuticals | Orlando, FL | No | FMD-145 Letter Issued 6/17/2026 | No | |
| SCA Pharmaceuticals | Windsor, CT | Yes | Response Letter Issued 10/19/2026 | No | |
| BayCare Integrated Service Center, LLC dba BayCare Central Pharmacy | Temple Terrace, FL | Yes | FMD-145 Letter Issued 9/18/2023 | No | |
| Staska Pharmaceuticals, Inc. | Bennet, NE | Yes | Response Letter Issued 7/23/2026 | No | |
| US Specialty Formulations LLC | Allentown, PA | Yes | Open | No | |
| F.H. Investments, Inc. | Birmingham, AL | Yes | Open | No | |
| Denver Solutions, LLC, dba Leiters Health | Englewood, CO | Yes | Untitled Letter Issued 6/8/2026 | No | |
| Nubratori, Inc. | Torrance, CA | Yes | Response Letter Issued 4/29/2026; Warning Letter Closeout Issued 7/27/2026; FMD-145 Issued 7/21/2026 | No | |
| Delta Pharma, Inc. | Ripley, MS | Yes | Open | No | |
| Empower Pharma | Houston, TX | Yes | Response Letter Issued 6/3/2026 | No | |
| OSRX, Inc. | Missoula, MT | Yes | Response Letter Issued 4/15/2026 | No | |
| Pine Pharmaceuticals, LLC | Tonawanda, NY | Yes | Warning Letter Issued 8/7/2026 | No | |
| Fresenius Kabi Compounding LLC dba Fagron Sterile Services | Canton, MA | Yes | Warning Letter Issued 5/12/2026 | No | |
| SCA Pharmaceuticals | Little Rock, AR | Yes | Warning Letter Issued 9/14/2026 | No | |
| Park Avenue Compounding | St. Louis, MO | Yes | Regulatory Meeting Held 5/7/2026 | No | |
| Central Admixture Pharmacy Services | Phoenix, AZ | Yes | Regulatory Meeting Held 5/5/2026 | No | |
| Central Admixture Pharmacy Services, Inc. | Allentown, PA | Yes | Regulatory Meeting Held 5/5/2026 | No | |
| Farmakeio Outsourcing LLC | Southlake, TX | Yes | Response Letter Issued 3/17/2026 | No | |
| Qualgen LLC | Edmond, OK | Yes | Response Letter Issued 10/26/2026 | No | |
| Nephron Sterile Compounding Center, LLC (NSCC) | West Columbia, SC | Yes | Open | No | |
| AnazaoHealth Corporation | Las Vegas, NV | Yes | Response Letter Issued 1/7/2026 | No | |
| Fagron Compounding Services dba Fagron Sterile Services | Wichita, KS | Yes | Regulatory Meeting Held 2/27/2026 | No | |
| GenoGenix LLC | Raton, FL | Yes | Open | Not published | |
| BSO LLC | Lakewood, CO | Yes | Regulatory Meeting Held 3/3/2026 | No | |
| Wedgewood Connect, LLC, formerly registered as Leiter's Compounding | San Jose, CA | Yes | Response Letter Issued 12/22/2025; FMD-145 Issued 1/2/2026 | No | |
| MedisourceRx | Los Alamitos, CA | Yes | Warning Letter Closeout Issued 7/27/2026 Warning Letter Issued 12/12/2025 | No | |
| Medi-Fare Drug | Blacksburg, SC | Yes | Response Letter Issued 12/19/2025 | No | |
| Stokes Healthcare Inc., dba Epicur Pharma | Mt. Laurel, NJ | Yes | Response Letter Issued 12/2/2025 | No |
Copied from FDA's table as updated November 17, 2026. A Form 483 lists investigators' observations; it is not a final agency determination. All 57 rows, with every column, are in the CSV and JSON.
How the number is computed
Facilities with a date in FDA's "Last Inspection" column are the denominator. The numerator is those whose "Form 483 Issued?" cell reads "Yes".
Included
- Every facility on FDA's 503B table with a published last-inspection date.
Excluded
- Facilities marked "Not yet inspected".
- Earlier inspections: FDA's table shows the most recent inspection only (a flag marks facilities with prior actions).
What this does not show
- A Form 483 records observations; it is not a finding that the law was broken.
- "Open" means FDA has not yet decided whether to act, not that a problem is unresolved.
- Inspection dates are FDA's: the day the Form 483 was issued, or the last day of the inspection when none was.
Recent changes to this page
- Source re-read by us; the figure reads 56 of 57 inspected 503B facilities issued a Form 483
- FDA table updated (U.S. Food and Drug Administration)
- Correction: 503B inspection findings: the denominator stated exactly
- Page published
A figure wrong? Tell us at hello@pricetrackerglp1.com. Every correction is dated on /corrections.
Receipts
2 sources · read November 18, 2026
- 01read
FDA, Registered Outsourcing Facilities (503B), updated November 17, 2026A Form FDA 483 is issued when investigators observe any significant objectionable conditions. It does not constitute a final agency determination of whether any condition is in violation of the FD&C Act or any relevant regulations.
- 02read
FDA, Registered Outsourcing Facilities (503B), updated November 17, 2026“Closed” means the inspection has been closed without further action. “Open” means FDA has not determined whether further action will be taken. If an action has been taken, it will be listed.
How to cite this page
Free to reuse under CC BY 4.0: quote the number, credit PriceTracker GLP-1 with a link, and name the federal source. The underlying records are public; our counts, matching and files are the work you are crediting.
PriceTracker GLP-1. (2026, November 18). Form FDA 483s at 503B outsourcing facility inspections [Data set]. Based on U.S. Food and Drug Administration data, fda table updated November 17, 2026. https://pricetrackerglp1.com/data/503b-inspection-findings
<p>56 of the 57 currently registered 503B outsourcing facilities with a published inspection date (98%) were issued a Form FDA 483 at their most recent inspection, according to FDA's Registered Outsourcing Facilities table updated November 17, 2026. Source: <a href="https://pricetrackerglp1.com/data/503b-inspection-findings">PriceTracker GLP-1</a> (CC BY 4.0).</p>
https://pricetrackerglp1.com/data/503b-inspection-findings.csv https://pricetrackerglp1.com/data/503b-inspection-findings.json
This statistic: common questions
What does this statistic count?
56 of the 57 currently registered 503B outsourcing facilities with a published inspection date (98%) were issued a Form FDA 483 at their most recent inspection, according to FDA's Registered Outsourcing Facilities table updated November 17, 2026.
How is the number computed?
Facilities with a date in FDA's "Last Inspection" column are the denominator. The numerator is those whose "Form 483 Issued?" cell reads "Yes".
Where does the data come from?
U.S. Food and Drug Administration: FDA, Registered Outsourcing Facilities (503B), updated November 17, 2026; FDA, Registered Outsourcing Facilities (503B), updated November 17, 2026. FDA table updated November 17, 2026; we last read it on November 18, 2026.
Can I reuse this data?
Yes, under CC BY 4.0: credit "PriceTracker GLP-1, pricetrackerglp1.com" with a link and name the federal source. Every row is in the CSV (https://pricetrackerglp1.com/data/503b-inspection-findings.csv) and the JSON (https://pricetrackerglp1.com/data/503b-inspection-findings.json).



